Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer

Multidrug resistance (MDR) is a major obstacle to successful cancer treatment and is crucial to cancer metastasis and relapse. Combination therapy is an effective strategy for overcoming MDR. However, the different pharmacokinetic (PK) profiles of combined drugs often undermine the combination effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Meng, Liu, Ergang, Cui, Yanna, Huang, Yongzhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570599/
https://www.ncbi.nlm.nih.gov/pubmed/28884039
http://dx.doi.org/10.20892/j.issn.2095-3941.2017.0054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570599/
https://www.ncbi.nlm.nih.gov/pubmed/28884039
http://dx.doi.org/10.20892/j.issn.2095-3941.2017.0054

Ejemplares similares